摘要
目的了解天津市某肿瘤专科医院抗菌药物的使用情况及用药趋势,为临床合理用药提供参考。方法选取医院2018年1月—2021年1月的资料,对抗菌药物使用率、用药频度(defined daily doses,DDDs)、抗菌药物使用强度(antibiotics use density,AUD)、日均费用(defined daily cost,DDC)和排序比(B/A)等进行统计分析。结果2018—2021年,医院抗菌药物使用量、抗菌药物使用率和AUD均呈现下降趋势。抗菌药物使用率年均值为22.42%,AUD年均值为26.79 DDDs/(100人·天)。抗菌药物年使用量和DDDs排在前3位的是头孢菌素类、碳青酶烯类和青霉素类。抗菌药物以非限制使用级为主。DDC>100的抗菌药物有6种。DDC最高的是伏立康唑。环丙沙星氯化钠、莫西沙星片、拉氧头孢钠、莫西沙星氯化钠的B/A接近或等于1,说明这些抗菌药物同步性较好。结论2018—2021年天津市某肿瘤专科医院抗菌药物的选择与使用较为合理,临床应用指标符合国家标准要求。
Objective To investigate the use and application trend of antibiotics in a cancer hospital in Tianjin,so as to provide reference for the rational clinical use of antibiotics.Methods The related data of antibiotics in the hospital from January 2018 to January 2021 were selected,and the utilization rate,defined daily doses(DDDs)of drugs,antibiotics use density(AUD),defined daily cost(DDC)and ranking ratio(B/A)of antibiotics were statistically analyzed.Results In 2018-2021,the annual use of antibiotics,utilization rate of antibiotics and AUD showed a downward trend.The mean annual utilization rate of antibiotics was 22.42%,and the mean annual AUD was 26.79 DDDs/(100 person.d).The top three antibacterial drugs in terms of annual consumption and DDDs were cephalosporins,carbapenems and penicillins.The main antibacterial drugs at all levels were unrestricted.There were 6 antibacterial drugs with DDC>100.Voriconazole had the highest DDC.The B/A of ciprofloxacin sodium chloride,moxifloxacin tablets,Latoxefin sodium,moxifloxacin sodium chloride was close to or equal to 1,indicating that the synchronization of these antibacterial drugs was good.Conclusion In 2018-2021,the selection and use of antibiotics in the cancer hospital in Tianjin was reasonable,and the clinical application indicators met the national standards.
作者
文柳静
张洁
Wen Liu-jing;Zhang Jie(Tianjin Medical University Cancer Institute&Hospital/National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy,Tianjin,300060,China;不详)
出处
《中国医院管理》
北大核心
2024年第3期84-88,共5页
Chinese Hospital Management
基金
国家卫生健康委医院管理研究所医院药学高质量发展研究项目(NIHAYS2319)。
